#news #biotech Merck, via its Themis buy, to move first COVID-19 vaccine into clinical development in Q3

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Merck, via its Themis buy, to move first COVID-19 vaccine into clinical development in Q3 .Merck, via its Themis buy, to move first COVID-19 vaccine into clinical development in Q3
badams
Fri, 07/31/2020 – 08:33




from FierceBiotech: Biotech https://ift.tt/2Ppbj5b